Skip to main content
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1991 Nov;44(11):960–961. doi: 10.1136/jcp.44.11.960

Lack of c-erbB-2 oncoprotein expression in male breast carcinoma.

S B Fox 1, C A Day 1, S Rogers 1
PMCID: PMC496642  PMID: 1684366

Abstract

A series of 21 male breast carcinomas were immunostained using NCL-CB11, an antibody directed against the internal domain of the c-erbB-2 transmembrane oncoprotein. In contrast to female breast cancer, where up to 35% of cases show positivity, all of these cases were negative. This suggests that no prognostic information regarding patient survival can be made in these patients and that male breast carcinomas may be under different growth control mechanisms from female breast carcinomas.

Full text

PDF
960

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Corbett I. P., Henry J. A., Angus B., Watchorn C. J., Wilkinson L., Hennessy C., Gullick W. J., Tuzi N. L., May F. E., Westley B. R. NCL-CB11, a new monoclonal antibody recognizing the internal domain of the c-erbB-2 oncogene protein effective for use on formalin-fixed, paraffin-embedded tissue. J Pathol. 1990 May;161(1):15–25. doi: 10.1002/path.1711610105. [DOI] [PubMed] [Google Scholar]
  2. Heintz N. H., Leslie K. O., Rogers L. A., Howard P. L. Amplification of the c-erb B-2 oncogene and prognosis of breast adenocarcinoma. Arch Pathol Lab Med. 1990 Feb;114(2):160–163. [PubMed] [Google Scholar]
  3. Keatings L., Sinclair J., Wright C., Corbett I. P., Watchorn C., Hennessy C., Angus B., Lennard T., Horne C. H. c-erbB-2 oncoprotein expression in mammary and extramammary Paget's disease: an immunohistochemical study. Histopathology. 1990 Sep;17(3):243–247. doi: 10.1111/j.1365-2559.1990.tb00714.x. [DOI] [PubMed] [Google Scholar]
  4. Korenman S. G. The endocrinology of the abnormal male breast. Ann N Y Acad Sci. 1986;464:400–408. doi: 10.1111/j.1749-6632.1986.tb16019.x. [DOI] [PubMed] [Google Scholar]
  5. McCann A., Dervan P. A., Johnston P. A., Gullick W. J., Carney D. N. c-erbB-2 oncoprotein expression in primary human tumors. Cancer. 1990 Jan 1;65(1):88–92. doi: 10.1002/1097-0142(19900101)65:1<88::aid-cncr2820650119>3.0.co;2-z. [DOI] [PubMed] [Google Scholar]
  6. Rose D. P. Endocrine epidemiology of male breast cancer (review). Anticancer Res. 1988 Jul-Aug;8(4):845–850. [PubMed] [Google Scholar]
  7. Tsutsumi Y., Naber S. P., DeLellis R. A., Wolfe H. J., Marks P. J., McKenzie S. J., Yin S. neu oncogene protein and epidermal growth factor receptor are independently expressed in benign and malignant breast tissues. Hum Pathol. 1990 Jul;21(7):750–758. doi: 10.1016/0046-8177(90)90035-4. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES